Chang David D., CEO of Allogene Therapeutics ALLO, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $289.5K. The latest trade was on 03/16.

CD

CD

Chang David D.

President and CEO

Company

Allogene Therapeutics ALLO

First filing

23/03/16

Trades

15 trades

Buys / sales

0 / 4

12-month net buying

−$289.5K

Last trade

03/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Allogene TherapeuticsALLO	Open-market sale	03/16	03/18	47,763 sh	$2.47	$117,974.61	−0.9%
Allogene TherapeuticsALLO	Open-market sale	02/02	02/04	95,269 sh	$1.80	$171,484.2	−1.8%
Allogene TherapeuticsALLO	Open-market sale	25/03/14	25/03/18	46,668 sh	$1.96	$91,469.28	−0.9%
Allogene TherapeuticsALLO	Open-market sale	25/02/03	25/02/05	46,003 sh	$1.68	$77,285.04	−0.9%